ACCESSION: MSBNK-SMB_Measured-HSA001P0154000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'BLK01_1238': {'bp': 344542.0, 'sum': 900666.0}, '18_posi_1658': {'bp': 263228.0, 'sum': 645139.0}, '7_posi_1658': {'bp': 260953.0, 'sum': 660486.0}, '19_posi_1950': {'bp': 256108.0, 'sum': 622597.0}, '19_posi_1363': {'bp': 249835.0, 'sum': 653880.0}, '19_posi_1614': {'bp': 242055.0, 'sum': 602773.0}, '18_posi_1550': {'bp': 237676.0, 'sum': 603105.0}, '19_posi_1784': {'bp': 236734.0, 'sum': 570964.0}, '4_posi_1658': {'bp': 231843.0, 'sum': 605596.0}, '19_posi_1237': {'bp': 221233.0, 'sum': 582593.0}, '19_posi_1866': {'bp': 220987.0, 'sum': 575072.0}}
COMMENT: RETENTION_TIME_STDEV 0.474
COMMENT: PRECURSOR_M/Z_RAW 154.097164
COMMENT: PRECURSOR_M/Z_STDEV 0.000054
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.105; C7H11N3O; [M+H]+; delta(ppm) 0.104514
COMMENT: PROPOSED_MF MS-FINDER 4.375; C7H11N3O; [M+H]+; delta(ppm) 0.101059
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.103; C7H11N3O; [M+H]+; delta(ppm) 0.101059
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.349; C4H12FN3O2; [M+H]+; delta(ppm) -7.314023
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.785; C9H13O2; [M+H]+; delta(ppm) -8.611945
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.304; C5H9N6; [M+H]+; delta(ppm) 8.814215
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.510; C3H14N4OP; [M+H]+; delta(ppm) -1.904830
COMMENT: PROPOSED_MF SIRIUS6_Sirius -7.209; CH12N7P; [M+H]+; delta(ppm) 6.808291
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.998; C7H11N3O; [M+H]+; delta(ppm) 0.101059
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C4H12FN3O2; [M+H]+; delta(ppm) -7.314023
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.915; XJWPISBUKWZALE-UHFFFAOYSA-N; [M+H]+; N-Acetylhistamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.618; HBGSUOAVQMQYCX-MLHKIVSYNA-N; [M+H]+; UNPD132356
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.594; LAYLNDKSJFJFGU-UHFFFAOYSA-N; [M+H]+; 2-methyl-5H,6H,7H,8H-2??-imidazo[1,5-c]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.562; DAAYGLKRMDTNSS-UHFFFAOYSA-N; [M+H]+; 2,4-diamino-6-hydroxylaminotoluene
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.510; IFOLNWVBRSCJOJ-UHFFFAOYSA-N; [M+H]+; 4,5-dimethyl-2-(methylamino)-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; HBGSUOAVQMQYCX-MLHKIVSYNA-N; [M+H]+; UNPD132356
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; IFOLNWVBRSCJOJ-UHFFFAOYSA-N; [M+H]+; 4,5-dimethyl-2-(methylamino)-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.717; DAAYGLKRMDTNSS-UHFFFAOYSA-N; [M+H]+; 2,4-diamino-6-hydroxylaminotoluene
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.640; XJWPISBUKWZALE-UHFFFAOYSA-N; [M+H]+; N-Acetylhistamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.163; ATCBPVDYYNJHSG-UHFFFAOYSA-N; [M+H]+; 6-methoxy-2-N-methylpyridine-2,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.005; IFOLNWVBRSCJOJ-UHFFFAOYSA-N; [M+H]+; 4,5-dimethyl-2-(methylamino)-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.985; LBVMECGJURCSOI-UHFFFAOYSA-N; [M+H]+; 2,5,6,7,8,9-hexahydro-[1,2,4]triazolo[4,3-a]azepin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; AANMRCRZPIYSQJ-UHFFFAOYSA-N; [M+H]+; 3-cyclopentyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.165; KERYLWAUHKMDMD-UHFFFAOYSA-N; [M+H]+; 3-oxo-3-piperazin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.147; ZMMAKUGJTOHVRG-UHFFFAOYSA-N; [M+H]+; 5-cyclopentyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.021; UMTWOZPNHLHVDM-UHFFFAOYSA-N; [M+H]+; 1-(3-aminopropyl)pyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; BRXARUGTCROZDQ-UHFFFAOYSA-N; [M+H]+; 1-amino-6,7,8,8a-tetrahydro-3H-pyrrolo[1,2-a]pyrazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; DAAYGLKRMDTNSS-UHFFFAOYSA-N; [M+H]+; N-(3,5-diamino-2-methylphenyl)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; NXIFLFFIQCQPGP-UHFFFAOYSA-N; [M+H]+; 5-pyrrolidin-3-yl-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; LJBDMFLWAOHEMP-UHFFFAOYSA-N; [M+H]+; 1-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[3,4-c]pyridin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; WUOZWHQSSQVLPW-UHFFFAOYSA-N; [M+H]+; 2,4,5,6,7,8-hexahydro-1H-pyrazolo[3,4-d]azepin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; NTUNUJOFFAFXTP-UHFFFAOYSA-N; [M+H]+; 3-(2-aminoethyl)-6-methylpyrimidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.967; WMEFWFJFVFFUTA-UHFFFAOYSA-N; [M+H]+; 3-(2-aminopyrimidin-5-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.966; VOAVOYSXTGRPQE-UHFFFAOYSA-N; [M+H]+; 2-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; YDKMMXBPUCTFTD-UHFFFAOYSA-N; [M+H]+; 2-piperidin-4-yl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.942; CUZDRVAZVXAEMK-UHFFFAOYSA-N; [M+H]+; 2-piperidin-3-yl-1,3,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.940; UMAJZZHMXMIDID-UHFFFAOYSA-N; [M+H]+; 1-tert-butyltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; WEEAFBUWHXMBRB-UHFFFAOYSA-N; [M+H]+; 1-(2-methylpropyl)triazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; ORFXJJVVHVUFCG-UHFFFAOYSA-N; [M+H]+; 3-piperidin-4-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.925; FAPUBBZZFHTOQQ-UHFFFAOYSA-N; [M+H]+; 3-piperidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; QZMJEMVLACLWBF-UHFFFAOYSA-N; [M+H]+; 4-amino-5-ethyl-2-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; QIZNVEHPEPIHKF-UHFFFAOYSA-N; [M+H]+; 4-amino-5-propyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; JMPZLHXAOVMOHR-UHFFFAOYSA-N; [M+H]+; 4-(2-aminoethyl)-2-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.897; MUPDMFBZUPTAAN-UHFFFAOYSA-N; [M+H]+; 1-methyl-6,7-dihydro-4H-pyrano[3,4-d]imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; LFGAVXRHHARQKL-UHFFFAOYSA-N; [M+H]+; 5-piperidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; BKYBBCQYORLQOT-UHFFFAOYSA-N; [M+H]+; 5-piperidin-4-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; IFFLWHXSAKIHCW-UHFFFAOYSA-N; [M+H]+; 5-(oxolan-3-yl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.891; CKIXUKPEHKUCPP-UHFFFAOYSA-N; [M+H]+; 5-(oxolan-2-yl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; SNTPZIMGOURHPE-UHFFFAOYSA-N; [M+H]+; 2-tert-butyl-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; OSDDKBZCCWOUAQ-UHFFFAOYSA-N; [M+H]+; 1-methyl-6,7-dihydro-4H-pyrano[4,3-c]pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; GKDSEIBRVPBLDD-UHFFFAOYSA-N; [M+H]+; 6-methyl-6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.868; MKFUJNJNKHEQTE-UHFFFAOYSA-N; [M+H]+; 2-[(3-aminopyridin-4-yl)amino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; NYVUTBBNLILMOD-UHFFFAOYSA-N; [M+H]+; 3-(2-methylpyrazol-3-yl)azetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; ZFUKNDRYQWGFJE-UHFFFAOYSA-N; [M+H]+; 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; ROPAYOUEKKPZNL-UHFFFAOYSA-N; [M+H]+; 3-amino-2-pyrazol-1-ylcyclobutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; NBPLTTYVAHCBCP-UHFFFAOYSA-N; [M+H]+; 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.865; QKOWKLCCBNGSLY-RNFRBKRXSA-N; [M+H]+; (1R,2R)-2-(1,2,4-triazol-4-yl)cyclopentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; MKUFYSSAOGGRMX-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)-3-methylimidazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.850; NIUGRDGIDVRQML-UHFFFAOYSA-N; [M+H]+; 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; VXUMQPPXFQVYTM-UHFFFAOYSA-N; [M+H]+; (4-cyclopropyl-5-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; NWGCJPPWQVPERJ-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; MDAAYJPPOBUTNZ-UHFFFAOYSA-N; [M+H]+; (5-cyclopropyl-4-methyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.849; DPCAZQLZRINJJY-UHFFFAOYSA-N; [M+H]+; 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-b]pyridin-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; BHJLUJCXXFFAAT-UHFFFAOYSA-N; [M+H]+; 3-(1H-pyrazol-5-yl)pyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; XJPLEIAWEVAOKG-UHFFFAOYSA-N; [M+H]+; 3-(1H-pyrazol-5-ylmethyl)azetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; AXNWSEUPMZVCJZ-UHFFFAOYSA-N; [M+H]+; 1-(6-methoxypyridazin-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.831; FBYLGQQDYJAERJ-UHFFFAOYSA-N; [M+H]+; 4-(1H-pyrazol-5-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.831; NKLKKQNSAFCHLV-UHFFFAOYSA-N; [M+H]+; 2-(5-aminopyrazin-2-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; WCZSOFQPRHJEAM-UHFFFAOYSA-N; [M+H]+; 2-[(3-aminopyridin-2-yl)amino]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.829; HQEKHMWCJJVBKW-UHFFFAOYSA-N; [M+H]+; 3-(1-methylimidazol-2-yl)azetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.817; HYIOOBSVQLUCSH-UHFFFAOYSA-N; [M+H]+; 3-methyl-3-(1,2,4-triazol-1-yl)butan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.814; JYVDDHHGTANDEG-UHFFFAOYSA-N; [M+H]+; 2-(2-methoxypyrimidin-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; JNGLFUNIUKIGHZ-UHFFFAOYSA-N; [M+H]+; 2-(4-methoxypyrimidin-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; JBTFRSJVFVPNHP-UHFFFAOYSA-N; [M+H]+; 2-(methoxymethyl)-4-methylpyrimidin-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.807; GPRVTGXMHAXWRK-UHFFFAOYSA-N; [M+H]+; 2-methyl-6,7-dihydro-4H-pyrano[4,3-c]pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; AMTJXKSIHPLYQB-UHFFFAOYSA-N; [M+H]+; 3-methyl-5-pyrrolidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; HVPGJKMIHQOPDG-UHFFFAOYSA-N; [M+H]+; 3-methyl-5-pyrrolidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.802; SHJPGPOPDVKKDN-UHFFFAOYSA-N; [M+H]+; 1-(5-methyl-1,2,4-oxadiazol-3-yl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.798; RFNIUBLYJWOZHO-UHFFFAOYSA-N; [M+H]+; 5-methyl-3-pyrrolidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; RFIKUEFSGRDOMQ-UHFFFAOYSA-N; [M+H]+; 5-methyl-3-pyrrolidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.792; RGKZCZIGCORBNH-UHFFFAOYSA-N; [M+H]+; 3-(2-methylpyrazol-3-yl)oxetan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.791; BAAYRLPQYMEVTH-UHFFFAOYSA-N; [M+H]+; 5,6,8,9-tetrahydroimidazo[1,2-d][1,4]oxazepin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.782; BKXLCMMXOWRLLA-UHFFFAOYSA-N; [M+H]+; 2-piperazin-1-yl-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; VOEMFJWEONPRDK-UHFFFAOYSA-N; [M+H]+; 2-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.742; OKTGPAFNRWIJFF-UHFFFAOYSA-N; [M+H]+; 3-(5-methyl-1,3,4-oxadiazol-2-yl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.253; KMGHOGSBGFJQQC-UHFFFAOYSA-N; [M+H]+; 2-(1H-imidazol-2-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.253; CGSRUYGJCQXWDO-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.252; FROPILFAPSIWMO-UHFFFAOYSA-N; [M+H]+; 6-propan-2-yloxypyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.252; UWUDAKQYIYHYGD-UHFFFAOYSA-N; [M+H]+; 2-(1-methylpyrrol-2-yl)acetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.251; XUQBBXUXOGOWMK-UHFFFAOYSA-N; [M+H]+; N-(1-ethylpyrazol-3-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.251; FZVHDWASRWQFIK-UHFFFAOYSA-N; [M+H]+; 3-propoxypyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; HHIUHYLOJFTTJK-UHFFFAOYSA-N; [M+H]+; 2-(1H-pyrazol-5-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; MZYXOBFXZUGSPW-UHFFFAOYSA-N; [M+H]+; 2-propan-2-yloxypyrimidin-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; AMFQYEHVISAILF-UHFFFAOYSA-N; [M+H]+; 3-pyrimidin-2-yloxypropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; BNUMHWPXAWWQCB-UHFFFAOYSA-N; [M+H]+; 2-(oxolan-3-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; RMRVJLDOZUHEHZ-UHFFFAOYSA-N; [M+H]+; 1,3-dimethyl-5,6-dihydro-4H-pyrazolo[3,4-b][1,4]oxazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; JNMNEKBPYOEAJS-UHFFFAOYSA-N; [M+H]+; 3-(dimethylamino)-6-methyl-1H-pyridazin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; FAHSHESULNYEEV-UHFFFAOYSA-N; [M+H]+; 3-ethoxy-5,6-dimethyl-1,2,4-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; FYOWFHLZOYSYHR-UHFFFAOYSA-N; [M+H]+; 1,4,6,7-tetrahydropyrano[3,4-d]imidazol-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; SGCCMCOUONCHOJ-UHFFFAOYSA-N; [M+H]+; (5-ethoxypyrazin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; QQEYAKUXPBQVFD-UHFFFAOYSA-N; [M+H]+; 6-propan-2-yloxypyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; LBKUYWUQXZOQRV-UHFFFAOYSA-N; [M+H]+; 6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; BDQOAGGSRPYRPG-UHFFFAOYSA-N; [M+H]+; 3-(1H-imidazol-2-yl)oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; MAOXUUQESAOWJS-RQJHMYQMSA-N; [M+H]+; (3S,4R)-4-imidazol-1-yloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.250; RLZUNNFCUKWDHZ-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydropyrazolo[5,1-b][1,3]oxazepin-3-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H12N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 3.206
MS$FOCUSED_ION: PRECURSOR_M/Z 154.097504
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-2900000000-f0c1948dd3330ccf2084
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0494571 15.4062 56.050089 1.5522 4.05 -0.1667 8 f{C3H6N1}/-0.33ppm,p-C4H6N2O1
  69.0447635 82.1011 69.045389 0.8256 13.56 0.6364 11 f{C3H5N2}/0.56ppm,p-C4H7N1O1
  71.0602941 40.3600 71.060907 0.7599 9.86 0.2818 11 f{C3H7N2}/-1.13ppm,p-C4H5N1O1
  72.0444108 57.1437 72.045017 1.4991 9.60 -0.1182 11 f{C3H6N1O1}/0.29ppm,p-C4H6N2
  83.0604254 69.5568 83.060929 1.3605 8.85 0.4091 11 f{C4H7N2}/0.61ppm,p-C3H5N1O1
  85.0759481 23.2146 85.076427 2.5742 7.95 0.4545 11 f{C4H9N2}/-0.90ppm,p-C3H3N1O1
  86.0600842 195.9691 86.060551 0.4648 39.16 0.2000 11 f{C4H8N1O1}/0.51ppm,p-C3H4N2
  95.0603290 24.7461 95.060689 1.8935 8.79 0.5333 9 f{C5H7N2}/-0.48ppm,p-C2H5N1O1
  97.0759928 22.9046 97.076338 1.7306 4.79 0.2333 9 f{C5H9N2}/-0.33ppm,p-C2H3N1O1
  99.0551842 33.9018 99.055514 1.8273 13.63 0.2091 11 f{C4H7N2O1}/-1.06ppm,p-C3H5N1
  109.0395727 36.7878 109.039810 1.8067 9.71 0.4636 11 f{C5H5N2O1}/-0.61ppm,p-C2H7N1
  109.0759531 20.4619 109.076190 1.5769 4.16 0.2364 10 f{C6H9N2}/-0.66ppm,p-C1H3N1O1
  111.0552496 29.4381 111.055465 1.1436 7.06 0.2000 11 f{C5H7N2O1}/-0.36ppm,p-C2H5N1
  111.0915999 29.7165 111.091815 1.1702 6.11 0.8000 11 f{C6H11N2}/-0.67ppm,p-C1H1N1O1
  113.0708991 38.0583 113.071093 0.8136 8.16 0.3091 11 f{C5H9N2O1}/-0.36ppm,p-C2H3N1
  125.0709150 24.0563 125.070956 1.5751 8.51 0.1545 11 f{C6H9N2O1}/-0.19ppm,p-C1H3N1
  126.0661672 38.3807 126.066194 0.7377 9.63 0.2091 11 f{C5H8N3O1}/-0.17ppm,p-C2H4
  126.1025041 59.9492 126.102531 1.7922 9.96 0.3545 11 f{C6H12N3}/-0.55ppm,p-C1O1
  137.0710165 112.2074 137.070923 1.5102 14.07 0.4455 11 f{C7H9N2O1}/0.56ppm,p-H3N1
  137.1072478 28.2509 137.107154 1.5900 8.27 0.5152 10 ?
  154.0612857 166.2146 154.061181 1.6097 16.81 0.4727 11 ?
  154.0974839 999.0000 154.097379 0.2661 0.00 1.0000 11 f{C7H12N3O1}/-0.03ppm,p
  154.1335430 209.8683 154.133438 1.1159 23.06 0.7182 11 ?
PK$NUM_PEAK: 23
PK$PEAK: m/z int. rel.int.
  56.049457 15.41 15
  69.044764 82.10 82
  71.060294 40.36 40
  72.044411 57.14 57
  83.060425 69.56 69
  85.075948 23.21 23
  86.060084 195.97 195
  95.060329 24.75 24
  97.075993 22.90 22
  99.055184 33.90 33
  109.039573 36.79 36
  109.075953 20.46 20
  111.055250 29.44 29
  111.091600 29.72 29
  113.070899 38.06 38
  125.070915 24.06 24
  126.066167 38.38 38
  126.102504 59.95 59
  137.071016 112.21 112
  137.107248 28.25 28
  154.061286 166.21 166
  154.097484 999.00 999
  154.133543 209.87 209
//
